1-14 of 14
Robert Zeillinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract AP15: IDENTIFICATION OF P53 PRIONS AS AN INDEPENDENT PROGNOSTIC MARKER FOR SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER

Nicole Heinzl, Elisabeth Maritschnegg, Katarzyna Koziel, Stuart Wilson, Georg Heinze, Christine Wallisch, Reinhard Horvat, Jalid Sehouli, Ioana Braicu, Ignace Vergote, Els van Nieuwenhuysen, Sven Mahner, Eva Obermayr, Eva Schuster, Barbara Holzer, Nicole Concin, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): AP15.
https://doi.org/10.1158/1557-3265.OVCASYMP18-AP15
Published: 15 November 2019
View articletitled, Abstract AP15: IDENTIFICATION OF P53 PRIONS AS AN INDEPENDENT PROGNOSTIC MARKER FOR SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER
Journal Articles

Abstract AP04: THE MOLECULAR DETECTION OF CIRCULATING TUMOR CELLS IN THE BLOOD OF OVARIAN CANCER PATIENTS

Eva Obermayr, Elisabeth Maritschnegg, Paul Speiser, Eva Schuster, Barbara Holzer, Nina Pecha, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): AP04.
https://doi.org/10.1158/1557-3265.OVCASYMP16-AP04
Published: 31 May 2017
View articletitled, Abstract AP04: THE MOLECULAR DETECTION OF CIRCULATING TUMOR CELLS IN THE BLOOD OF OVARIAN CANCER PATIENTS
Journal Articles

Abstract DPOC-009: DETECTION OF A CLINICALLY OCCULT OVARIAN CARCINOMA BY NEW DIAGNOSTIC TOOLS – A CASE REPORT

Elisabeth Maritschnegg, Eva Obermayr, Barbara Holzer, Noreen Gleeson, Florian Heitz, Leon Massuger, Gunda Pristauz Telsnigg, Adam Rosenthal, Fabian Trillsch, Els Van Nieuwenhuysen, Michael Zikan, Paul Speiser, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): DPOC-009.
https://doi.org/10.1158/1557-3265.OVCASYMP16-DPOC-009
Published: 31 May 2017
View articletitled, Abstract DPOC-009: DETECTION OF A CLINICALLY OCCULT OVARIAN CARCINOMA BY NEW DIAGNOSTIC TOOLS – A CASE REPORT
Journal Articles

Abstract A35: Olaparib causes premature loss of cohesion in cancer cells

Eva Kukolj, Tanja Kaufmann, Amalie E. Dick, Robert Zeillinger, Daniel W. Gerlich, Dea Slade
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1_Supplement): A35.
https://doi.org/10.1158/1557-3265.PMCCAVULN16-A35
Published: 02 January 2017
View articletitled, Abstract A35: Olaparib causes premature loss of cohesion in cancer cells
Journal Articles

Abstract B28: Validation of a combined 13 gene six protein blood signature for earlier detection of ovarian cancer.

Anna Bachmayr-Heyda, Stefanie Aust, Katharina Auer, Peter Borossay, Nina Pecha, Ugo Cavallaro, Ioana Braicu, Sarah Igidbashian, Costanza Savino, Franchi Dorella, Jalid Sehouli, Sonia Zaafrani, Florian Fitzal, Christian Singer, Michael Gnant, Robert Zeillinger, Dietmar Pils
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): B28.
https://doi.org/10.1158/1557-3265.OVCA15-B28
Published: 15 January 2016
View articletitled, Abstract B28: Validation of a combined 13 gene six protein blood signature for earlier detection of ovarian cancer.
Journal Articles

hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer

Michael Wittinger, Petr Vanhara, Ahmed El-Gazzar, Bettina Savarese-Brenner, Dietmar Pils, Mariam Anees, Thomas W. Grunt, Maria Sibilia, Martin Holcmann, Reinhard Horvat, Michael Schemper, Robert Zeillinger, Christian Schöfer, Helmut Dolznig, Peter Horak, Michael Krainer
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7816–7827.
https://doi.org/10.1158/1078-0432.CCR-11-0408
Published: 18 December 2011
View articletitled, hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer
Open the PDF for hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer

Lukas A. Hefler, Nicole Concin, Gerda Hofstetter, Christian Marth, Alexander Mustea, Jalid Sehouli, Robert Zeillinger, Heinz Leipold, Harald Lass, Christoph Grimm, Clemens B. Tempfer, Alexander Reinthaller
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 710–714.
https://doi.org/10.1158/1078-0432.CCR-07-1044
Published: 01 February 2008
View articletitled, Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer
Open the PDF for Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer in another window
Journal Articles

Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer

Lukas A. Hefler, Alexander Mustea, Dominique Könsgen, Nicole Concin, Berno Tanner, Reiner Strick, Georg Heinze, Christoph Grimm, Eva Schuster, Clemens Tempfer, Alexander Reinthaller, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (3): 898–901.
https://doi.org/10.1158/1078-0432.CCR-06-1008
Published: 08 February 2007
View articletitled, Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer
Open the PDF for Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer in another window
Journal Articles

Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer

Dan Tong, Klaus Czerwenka, Georg Heinze, Martin Ryffel, Eva Schuster, Armin Witt, Sepp Leodolter, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (8): 2442–2448.
https://doi.org/10.1158/1078-0432.CCR-05-0964
Published: 25 April 2006
View articletitled, Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer
Open the PDF for Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer in another window
Journal Articles

Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5

Peter Horak, Dietmar Pils, Alexandra Kaider, Alexander Pinter, Katarzyna Elandt, Cornelia Sax, Christoph C. Zielinski, Reinhard Horvat, Robert Zeillinger, Alexander Reinthaller, Michael Krainer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8585–8591.
https://doi.org/10.1158/1078-0432.CCR-05-1276
Published: 16 December 2005
View articletitled, Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5
Open the PDF for Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5 in another window
Journal Articles

Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo

Nicole Concin, Gerda Hofstetter, Astrid Berger, Adriana Gehmacher, Daniel Reimer, Rafal Watrowski, Dan Tong, Eva Schuster, Lukas Hefler, Kurt Heim, Elisabeth Mueller-Holzner, Christian Marth, Ute M. Moll, Alain G. Zeimet, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8372–8383.
https://doi.org/10.1158/1078-0432.CCR-05-0899
Published: 01 December 2005
View articletitled, Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo
Open the PDF for Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo in another window
Journal Articles

Interleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women

Lukas A. Hefler, Christoph Grimm, Tilmann Lantzsch, Dieter Lampe, Sepp Leodolter, Heinz Koelbl, Georg Heinze, Alexander Reinthaller, Dan Tong-Cacsire, Clemens Tempfer, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5718–5721.
https://doi.org/10.1158/1078-0432.CCR-05-0001
Published: 22 August 2005
View articletitled, Interleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women
Open the PDF for Interleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women in another window
Journal Articles

Vascular Endothelial Growth Factor Splice Variants and Their Prognostic Value in Breast and Ovarian Cancer

Margit Stimpfl, Dan Tong, Barbara Fasching, Eva Schuster, Andreas Obermair, Sepp Leodolter, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2253–2259.
Published: 01 July 2002
View articletitled, Vascular Endothelial Growth Factor Splice Variants and Their Prognostic Value in Breast and Ovarian Cancer
Open the PDF for Vascular Endothelial Growth Factor Splice Variants and Their Prognostic Value in Breast and Ovarian Cancer in another window
Journal Articles

Messenger RNA Determination of Estrogen Receptor, Progesterone Receptor, pS2, and Plasminogen Activator Inhibitor-1 by Competitive Reverse Transcription-Polymerase Chain Reaction in Human Breast Cancer

Dan Tong, Christian Schneeberger, Klaus Czerwenka, Rita K. Schmutzler, Paul Speiser, Elisabeth Kucera, Nicole Concin, Ernst Kubista, Sepp Leodolter, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (6): 1497–1502.
Published: 01 June 1999
View articletitled, Messenger RNA Determination of Estrogen Receptor, Progesterone Receptor, pS2, and Plasminogen Activator Inhibitor-1 by Competitive Reverse Transcription-Polymerase Chain Reaction in Human Breast Cancer
Open the PDF for Messenger RNA Determination of Estrogen Receptor, Progesterone Receptor, pS2, and Plasminogen Activator Inhibitor-1 by Competitive Reverse Transcription-Polymerase Chain Reaction in Human Breast Cancer in another window